11. Patients receiving a HER2 targeted monoclonal antibody must have adequate cardiac function, as demonstrated by normal left ventricular ejection fraction (LVEF) ≥ the lower limit of normal for the facility on MUGA scan or echocardiogram (ECHO) within 6 months of enrollment as per standard of care. B.